# EDGAR Filing Document

**Accession Number:** 0000021076
**File Stem:** 0000021076-25-000035
**Filing Date:** 2025-7
**Character Count:** 101410
**Document Hash:** ba3c0b7d2742206972ce68e9400f647b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000021076-25-000035.hdr.sgml**: 20250731

**ACCESSION NUMBER**: 0000021076-25-000035

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 18

**CONFORMED PERIOD OF REPORT**: 20250731

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250731

**DATE AS OF CHANGE**: 20250731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CLOROX CO /DE/
- **CENTRAL INDEX KEY:** 0000021076
- **STANDARD INDUSTRIAL CLASSIFICATION:** SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 310595760
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-07151
- **FILM NUMBER:** 251171800

**BUSINESS ADDRESS:**
- **STREET 1:** THE CLOROX COMPANY
- **STREET 2:** 1221 BROADWAY
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612-1888
- **BUSINESS PHONE:** 5102717000

**MAIL ADDRESS:**
- **STREET 1:** P.O. BOX 24305
- **CITY:** OAKLAND
- **STATE:** CA
- **ZIP:** 94612-1305

?xml version='1.0' encoding='ASCII'? clx-20250731

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549 __________________**

**FORM 8-K**

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 31, 2025

![Image_0.jpg](clx-20250731_g1.jpg)

THE CLOROX COMPANY

(Exact name of registrant as specified in its charter)

__________________

---

| | | |
|:---|:---|:---|
| Delaware | 1-07151 | 31-0595760 |
| (State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
| incorporation) | | Identification No.) |

---

**1221 Broadway, Oakland, California 94612-1888** (Address of principal executive offices) (Zip code)

**(510) 271-7000** (Registrant's telephone number, including area code)

**Not applicable** (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

---

| |
|:---|
| Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange on which registered** |
| Common Stock - $1.00 par value | CLX | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp; ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &nbsp;&nbsp;&nbsp;&nbsp;☐

------

**Item 2.02 Results of Operations and Financial Condition**

On July 31, 2025, The Clorox Company issued a press release announcing its financial results for its fourth quarter and fiscal year ended June 30, 2025. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

**Item 7.01 Regulation FD Disclosure**

Attached hereto as Exhibit 99.2 and incorporated herein by reference is supplemental financial information.

**Item 9.01 Financial Statements and Exhibits**

**(d) Exhibits**

See the Exhibit Index below.

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **Exhibit** | **Description** |
| <u>[99.1](ex991-pressreleasedatedjul.htm)</u> | <u>[Press Release dated](ex991-pressreleasedatedjul.htm)[July](ex991-pressreleasedatedjul.htm)[3](ex991-pressreleasedatedjul.htm)[1, 202](ex991-pressreleasedatedjul.htm)[5](ex991-pressreleasedatedjul.htm)[of The Clorox Company](ex991-pressreleasedatedjul.htm)</u> |
| <u>[99.2](ex992-supplementalinformat.htm)</u> | <u>[Supplemental information regarding financial results](ex992-supplementalinformat.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | THE CLOROX COMPANY | THE CLOROX COMPANY |
| Date: | July 31, 2025 | By: | /s/ Angela Hilt |
|  |  |  | Angela Hilt |
|  |  |  | Executive Vice President – Chief Legal and External Affairs Officer and Corporate Secretary |

---

## Exhibit 99.1

---

| | |
|:---|:---|
| **PRESS RELEASE** | ![clxlogoa.jpg](clxlogoa.jpg) |

---

![image_13a.jpg](image_13a.jpg)

Clorox Reports Q4 and FY25 Results, Provides FY26 Outlook

*Delivers strong margin expansion and adjusted EPS growth for FY25 despite challenging environment in the second half of the fiscal year* 

OAKLAND, California, July 31, 2025 — The Clorox Company (NYSE: CLX) today reported results for the fourth quarter and fiscal year 2025, which ended June 30, 2025.

**Fourth-Quarter Fiscal Year 2025 Summary**

The following is a summary of key fourth-quarter results, which reflect the temporary benefit from incremental shipments related to building retailer inventory in advance of the enterprise resource planning transition in the U.S. (incremental ERP shipments) and the impact from the prior divestiture of the Better Health Vitamins, Minerals and Supplements (VMS) business. All comparisons are with the fourth quarter of fiscal year 2024 unless otherwise stated.

• **Net sales** increased 4% to $2.0 billion, primarily driven by the impacts of the incremental ERP shipments, partially offset by the divestiture of the VMS business and unfavorable price mix. Organic sales<sup>1</sup> increased 8%. Incremental ERP shipments contributed about 13 to 14 points of benefit to net sales.

• **Gross margin** was 46.5%, essentially flat versus the year-ago quarter, primarily due to higher volume and cost savings, offset by both higher manufacturing and logistics costs and trade promotion spending. Incremental ERP shipments contributed about 150 basis points of benefit to gross margin.

• **Diluted net earnings per share (diluted EPS)** increased 55% to $2.68 from $1.73 in the year-ago quarter. The increase includes lapping the implementation of the company's streamlined operating model partially offset by insurance recoveries, net of incremental costs, related to the August 2023 cyberattack in the prior period.

• **Adjusted EPS**<sup>1</sup> increased 58% to $2.87 from $1.82 in the year-ago quarter, due in part to higher volume. The benefit from incremental ERP shipments is estimated to be about 85 to 95 cents.

"While we delivered strong margin expansion and adjusted EPS growth for the year, we did not meet our topline expectations in the back half. We continued to see rapidly shifting consumer behaviors and broader market volatility which we expect to continue," said Chair and CEO Linda Rendle. "At the same time, we advanced our long-term strategy and began the implementation of our new ERP system in the U.S. This digital transformation supports our long-term financial goals through modernized capabilities, which will accelerate growth and deliver stronger efficiencies. As we look to fiscal year 2026, we remain focused on operational excellence and driving category and market share improvements. With more work to do, we are confident in the strength of our strategy, the resilience of our portfolio of trusted brands, and our ability to deliver value for consumers, customers and shareholders over the long term."

*This press release includes certain non-GAAP financial measures. See "Non-GAAP Financial Information" at the end of this press release for more details.* 

<sup>1</sup> Organic sales growth/(decrease) and adjusted EPS are non-GAAP measures. See Non-GAAP Financial Information at the end of this press release for reconciliations to the most comparable GAAP measures.

------

**Strategic and Operational Highlights** 

The following are recent highlights of business achievements:

• Delivered another quarter of strong cost savings as part of the company's effort to expand margin while growing overall market shares and organic sales for the fiscal year.

• Executed strong preparation, which included building retailer inventory, ahead of its ERP launch in the U.S. at the beginning of fiscal year 2026 as part of its ongoing work to accelerate digital transformation through modernized technologies and processes.

• Continued to invest behind value superiority with innovations across major brands in fiscal year 2025, such as the relaunch of Poett's fragrance platform, enhanced durability in Glad ForceFlex MaxStrength trash bags, Fresh Step Heavy Duty and Health Monitoring Clumping Litter, Clorox Scentiva Bleach, the expansion of the Burt's Bees portfolio with Boosted Tinted Balm and Rescue Lip Relief, seven new Hidden Valley Ranch flavors as well as product partnerships with Hot Pockets, Taco Bell, Burger King, and DiGiorno.

• Named a Best Company to Work For by U.S. News & World Report, one of America's Greatest Workplaces by Newsweek and one of Forbes' Net-Zero Leaders.

**Key Segment Results**

The following is a summary of key fourth-quarter results by reportable segment. All comparisons are with the fourth quarter of fiscal year 2024, unless otherwise stated.

Net sales increased 4%, driven by 8 points of higher volume, partially offset by 4 points of unfavorable price mix. Higher volume was mainly driven by the incremental ERP shipments. Unfavorable price mix was driven mainly by unfavorable product mix and higher trade promotion, which was mainly driven by unfavorable trade expense timing.

<u>Health and Wellness</u> (Cleaning; Professional Products)

• Net sales increased 14%, driven by 18 points of higher volume, partially offset by 4 points of unfavorable price mix. Higher volume was mainly driven by the incremental ERP shipments. Unfavorable price mix was driven by higher trade promotion spending and strong shipments to the Club channel.

• Segment adjusted EBIT<sup>2</sup> increased 20%, primarily driven by higher net sales and lower advertising, partially offset by both higher selling and administrative costs and manufacturing and logistics costs.

<u>Household</u> (Bags and Wraps; Cat Litter; Grilling)

• Net sales increased 7%, driven by 13 points of higher volume, partially offset by 6 points of unfavorable price mix. Higher volume was mainly driven by the incremental ERP shipments, partially offset by lower consumption and increased competition. Unfavorable price mix was driven by unfavorable product mix, mainly due to Club merchandising in Litter.

• Segment adjusted EBIT increased 59%, primarily driven by higher volume.

<u>Lifestyle</u> (Food; Water Filtration; Natural Personal Care)

• Net sales increased 3%, driven by 8 points of higher volume, partially offset by 5 points of unfavorable price mix. Higher volume was mainly driven by the incremental ERP shipments, partially offset by lower consumption. Unfavorable price mix was driven by higher trade promotion spending and unfavorable product mix.

• Segment adjusted EBIT increased 54%, primarily driven by lower advertising.

<sup>2</sup> Adjusted EBIT is a non-GAAP measure. See Non-GAAP Financial Information at the end of this press release for reconciliations to the most comparable GAAP measures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 2 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

<u>International</u> (Sales Outside the U.S.)

• Net sales decreased 1%, mainly driven by 4 points of unfavorable price mix and 2 points of unfavorable foreign exchange rates, partially offset by 5 points of higher volume. Organic sales increased 1%. Higher volume was mainly driven by the incremental ERP shipments. Unfavorable price mix was driven by product mix and higher trade promotion spending.

• Segment adjusted EBIT increased 28%, primarily due to higher volume, both lower selling and administrative and advertising expenses, partially offset by unfavorable mix and higher trade promotion spending.

**Fiscal Year 2025 Summary**

The following is a summary of key fiscal year 2025 results, which reflect the incremental ERP shipments and the prior divestitures of the VMS and Argentina businesses. All comparisons are to fiscal year 2024.

• **Net sales** were essentially flat, primarily driven by 1 point of higher volume offset by 1 point of unfavorable price mix. Organic sales increased 5%. Incremental ERP shipments contributed about 3.5 to 4 points of benefit to net sales, which is expected to reverse in fiscal year 2026.

• **Gross margin** increased 220 basis points to 45.2% from 43.0% in the year-ago period. The increase was primarily driven by cost savings, higher volume and the benefits of the divestitures of the Better Health VMS and Argentina businesses, partially offset by higher trade promotion spending, unfavorable mix and higher manufacturing and logistics costs. The benefit from ERP incremental shipments is estimated to be about 50 basis points, which is expected to reverse in fiscal year 2026.

• **Diluted EPS** increased 190% to $6.52 from $2.25 in the year-ago period. This increase includes lapping the divestiture of the Argentina business, the pension settlement charge, implementation of the streamlined operating model in the prior period, and the current-period benefit of cyberattack insurance recoveries, partially offset by the loss on the sale of the VMS business. The benefit from ERP incremental shipments is estimated to be about 85 to 95 cents, which is expected to reverse in fiscal year 2026.

• **Adjusted EPS** increased 25% to $7.72 from $6.17, driven mainly by higher volume and cost savings initiatives. These factors were partially offset by unfavorable mix and higher trade promotion spending. The benefit from ERP incremental shipments is estimated to be about 85 to 95 cents, reflecting year-over-year growth of 14% to 15%, which is expected to reverse in fiscal year 2026.

• **Net cash provided by operations** was $981 million compared to $695 million in fiscal year 2024, representing a 41% increase.

**ERP Transition Impact**

During the fourth quarter of fiscal year 2025, retailers placed orders in advance of the company's ERP system transition in the U.S. to minimize any potential inventory impacts during the implementation phase. The shipments of incremental inventory provided a benefit to fourth quarter 2025 net sales. These shipments added about 3.5 to 4 points of sales and about 85 to 95 cents earnings per share to fiscal year 2025. The company expects retailers to draw down on this inventory during the company's ERP transition period, resulting in lower shipments. From a year-over-year sales growth perspective, the reduction in sales from this inventory draw down translates to about 7 to 8 points of decline as compared to the higher base in fiscal year 2025. Similarly, this inventory draw down is expected to reduce fiscal year 2026 earnings per share by about 85 to 95 cents. In comparison to the higher base in fiscal year 2025, this results in a year-over-year reduction of about 29% to 32% to fiscal year 2026 diluted earnings per share and about 22% to 25% to fiscal year 2026 adjusted earnings per share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 3 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

---

| | | |
|:---|:---|:---|
| **Fiscal year 2025** | **Fiscal year 2025** | **Fiscal year 2025** |
| **Net sales (percentage change versus the year ago period)** | **Net sales (percentage change versus the year ago period)** | **Net sales (percentage change versus the year ago period)** |
| | **Three months ended** | **Twelve months ended** |
| | **Jun. 30, 2025** | **Jun. 30, 2025** |
| Net sales growth / (decrease) (GAAP) | 4% | 0% |
| Add: Foreign Exchange |  |  |
| Add/(Subtract): Divestitures/acquisitions | 4 | 5 |
| **Organic sales growth / (decrease) (non-GAAP)** | **8%** | **5%** |
| Note: Approximate benefit from incremental shipments related to ERP transition | +13% to +14% | 3.5% to 4% |

---

---

| | | |
|:---|:---|:---|
| **Diluted earnings per share** | **Diluted earnings per share** | **Diluted earnings per share** |
| | **Three months ended** | **Twelve months ended** |
| | **Jun. 30, 2025** | **Jun. 30, 2025** |
| As reported (GAAP) | $2.68 | $6.52 |
| Loss on divestiture |  | 0.94 |
| Cyberattack costs, net of insurance recoveries |  | (0.42) |
| Digital capabilities and productivity enhancements investment | 0.19 | 0.68 |
| **As adjusted (non-GAAP)** | $**2.87** | $**7.72** |
| Note: Approximate benefit from incremental shipments related to ERP transition | $0.85 to $0.95 | $0.85 to $0.95 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 4 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

**Fiscal Year 2026 Outlook** 

The most significant assumption of the fiscal year 2026 outlook is the transitory impact related to the ERP transition in the U.S.

• Net sales are expected to be down 6% to 10% compared to the prior year. The company expects less than a point of negative impact from the divestiture of its VMS business and foreign exchange rate changes. Organic sales are expected to decrease 5% to 9%, including a negative impact of about 7 to 8 points related to the reversal of the impact from incremental shipments associated with the ERP transition in the prior fiscal year.

• Gross margin is expected to be down 50 to 100 basis points. The reversal of the impact from incremental shipments associated with ERP transition in the prior fiscal year is expected to result in about a 100 basis points of headwinds.

• Selling and administrative expenses are expected to be about 16% of net sales, which includes about 90 basis points of impact from the company's strategic investments in digital capabilities and productivity enhancements.

• Advertising and sales promotion spending is expected to be about 11% of net sales, reflecting the company's ongoing commitment to invest behind its brands.

• The company's effective tax rate is expected to be about 24%.

• Diluted EPS is expected to be between $5.60 and $5.95, a year-over-year decrease of 14% to 9%, respectively. This includes the negative impact of about 85 to 95 cents related to the reversal of the impact from incremental shipments associated with the ERP transition in the prior fiscal year.

• Adjusted EPS is expected to be between $5.95 and $6.30, or a decrease between 23% and 18%, respectively. Adjusted EPS excludes the long-term strategic investment in digital capabilities and productivity enhancements, estimated to be about 35 cents. This includes the negative impact of about 85 to 95 cents related to the reversal of the impact from incremental shipments associated with the ERP transition in the prior fiscal year.

---

| | | | |
|:---|:---|:---|:---|
| **Net sales (percentage change versus the year ago period)** | **Net sales (percentage change versus the year ago period)** | **Net sales (percentage change versus the year ago period)** | **Net sales (percentage change versus the year ago period)** |
| | | **Fiscal year 2026 full year outlook** | **Fiscal year 2026 full year outlook** |
| | **Fiscal year 2025 full year**<br>**Impact** | **Low** | **High** |
| Net sales growth / (decrease) (GAAP) | 0% | (10)% | (6)% |
| Add: Foreign Exchange | **—** |  |  |
| Add/(Subtract): Divestitures/acquisitions | 5 | <1 | <1 |
| **Organic sales growth / (decrease) (non-GAAP)** | **5%** | **(9)%** | **(5)%** |
| Note: Expected impact from incremental shipments related to ERP transition | 3.5% to 4% | (8)% | (7)% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 5 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

---

| | | | |
|:---|:---|:---|:---|
| **Diluted earnings per share** | **Diluted earnings per share** | **Diluted earnings per share** | **Diluted earnings per share** |
| | | **Fiscal year 2026 full year outlook** | **Fiscal year 2026 full year outlook** |
| | **Fiscal year 2025 full year**<br>**Impact** | **Low** | **High** |
| As estimated (GAAP) | $6.52 | $5.60 | $5.95 |
| Loss on divestiture | 0.94 |  |  |
| Cyberattack costs, net of insurance recoveries | (0.42) |  |  |
| Digital capabilities and productivity enhancements investment | 0.68 | 0.35 | 0.35 |
| **As adjusted (non-GAAP)** | $**7.72** | $**5.95** | $**6.30** |
| Note: Expected impact from incremental shipments related to ERP transition | $0.85 to $0.95 | $(0.95) | $(0.85) |

---

**Clorox Earnings Conference Call Schedule** 

At approximately 4:15 p.m. ET today, Clorox will post prepared management remarks regarding its fourth-quarter and fiscal year 2025 results.

At 5 p.m. ET today, the company will host a live Q&A audio webcast with Chair and CEO Linda Rendle and Chief Financial Officer Luc Bellet to discuss the results.

Links to the live (and archived) webcast, press release and prepared remarks can be found at <u>Clorox Quarterly Results</u>.

**For More Detailed Financial Information**

Visit the company's <u>Quarterly Results</u> for the following:

• Supplemental unaudited volume and sales growth information

• Supplemental unaudited gross margin drivers information

• Supplemental unaudited cash flow information and free cash flow reconciliation

• Supplemental unaudited reconciliation of earnings (losses) before income taxes to EBIT and adjusted EBIT

• Supplemental unaudited reconciliation of adjusted earnings per share (EPS) and adjusted effective tax rate (ETR)

Note: Percentage and basis-point, or point, changes noted in this press release are calculated based on rounded numbers, except for per-share data and the effective tax rate.

**About The Clorox Company**

The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well as international brands such as Chux®, Clorinda®, and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first in the U.S. to integrate sustainability into its business reporting. In 2025, the company was ranked No. 1 on Barron's 100 Most Sustainable Companies list for the third consecutive year. Visit thecloroxcompany.com to learn more.

**Media Relations**

corporate.communications@clorox.com

**Investor Relations**

investorrelations@clorox.com

CLX-F

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 6 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

***Forward-Looking Statements***

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and any such forward-looking statements involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management's estimates, beliefs, assumptions and projections. Words such as "could," "may," "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," "will," "predicts," and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management's expectations, are described in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2024, as updated from time to time in the company's Securities and Exchange Commission filings. These factors include, but are not limited to: unfavorable general economic and geopolitical conditions beyond our control, including supply chain disruptions, labor shortages, wage pressures, rising inflation, the interest rate environment, fuel and energy costs, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, such as COVID-19, terrorism, and unstable geopolitical conditions, including ongoing conflicts/rising tensions in the Middle East and/or Ukraine and rising tensions between China and Taiwan, as well as macroeconomic and geopolitical volatility and uncertainty as a result of a number of these and other factors, including actual and potential shifts in U.S. and foreign trade policies, including as a result of escalating trade tensions and tariffs between the U.S. and its trading partners, especially China; the ability of the company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix; the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences; our recovery from the August 2023 cyberattack, and risks related to the company's use of and reliance on information technology systems, including potential and actual security breaches, cyberattacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or company information, business, service or operational disruptions, or that impact the company's financial results or financial reporting, or any resulting unfavorable outcomes, increased costs or legal proceedings; intense competition in the company's markets; volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services; risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers; the ability of the company to implement and generate cost savings and efficiencies, and successfully implement its transformational initiatives or strategies, including achieving anticipated benefits and cost savings from the implementation of the streamlined operating model and digital capabilities and productivity enhancements, and the timing and volume of shipment movement related to its ERP transition in the U.S.; the company's ability to maintain its business reputation and the reputation of its brands and products; dependence on key customers and risks related to customer consolidation and ordering patterns; the ability of the company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries; the company's ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as increasing labor costs and sustained labor shortages; lower revenue, increased costs or reputational harm resulting from government actions, compliance with regulations, and regulatory uncertainty, or any material costs imposed by changes in regulation; changes to our processes and procedures as a result of our digital capabilities and productivity enhancements investment that may result in changes to the company's internal controls over financial reporting; the ability of the company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity; risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 7 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

changes in governmental policies, including trade policy and tariffs, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; potential operational or supply chain disruptions from wars and military conflicts, including ongoing conflicts/rising tensions in the Middle East and/or Ukraine and rising tensions between China and Taiwan; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action; the impact of sustainability issues, including those related to climate-related transition risks, changing consumer preferences, including the environmental impact of the Company's products and sustainability on our sales, operating costs or reputation; the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls; risks relating to acquisitions, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks and goodwill; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions; the accuracy of the company's estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based; risks related to the acquisition of The Procter & Gamble Company's interest in the Glad business; risks related to our reliance on third-party service providers, including inability to meet cost savings or efficiencies, business or systems disruptions, and other liabilities, including legal or regulatory risk; environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances; the company's ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the company of third-party intellectual property rights; the effect of the company's indebtedness and credit rating on its business operations and financial results and the company's ability to access capital markets and other funding sources, as well as the cost of capital to the company; the company's ability to pay and declare dividends or repurchase its stock in the future; the impacts of potential stockholder activism; and risks related to any litigation associated with the exclusive forum provision in the company's bylaws.

The company's forward-looking statements in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this press release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

**Non-GAAP Financial Information**

• This press release contains non-GAAP financial information related to organic sales growth / (decrease), adjusted EPS, adjusted ETR and segment adjusted EBIT for the fourth quarter of fiscal year 2025 and for fiscal year 2025; as well as organic sales growth / (decrease) and adjusted EPS outlook for fiscal year 2026. The reasons management believes these measures are useful to investors are described below. Certain non-GAAP financial measures may be considered in determining incentive compensation.

• Clorox defines organic sales growth / (decrease) as GAAP net sales growth / (decrease) excluding the effect of foreign exchange rate changes and any acquisitions or divestitures.

• Organic sales growth / (decrease) outlook for fiscal year 2026 excludes less than a point of negative impact from divestiture of its VMS business and foreign exchange rate changes.

• Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the company was operating and expects to continue to operate throughout the relevant periods, and the company's estimate of the impact of foreign exchange rate changes, which are difficult to predict and out of the control of the company and management. However, organic sales growth / (decrease) may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 8 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

• Adjusted EPS is defined as diluted earnings per share that excludes or has otherwise been adjusted for significant items that are nonrecurring or unusual. The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

• Adjusted ETR is defined as the effective tax rate that excludes or that has otherwise been adjusted for significant items that are nonrecurring or unusual.

• Adjusted EPS and adjusted ETR are supplemental information that management uses to help evaluate the company's historical and prospective financial performance on a consistent basis over time. Management believes that by adjusting for certain items affecting comparability of performance over time, such as the pension settlement charge, incremental costs and insurance recoveries related to the August 2023 cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions / divestitures and other nonrecurring or unusual items, investors and management are able to gain additional insight into the company's underlying operating performance on a consistent basis over time. However, adjusted EPS and adjusted ETR may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.

• Adjusted EBIT represents earnings (losses) before income taxes excluding interest income, interest expense and other significant items that are nonrecurring or unusual (such as the pension settlement charge, incremental costs and insurance recoveries related to the August 2023 cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions / divestitures and other nonrecurring or unusual items impacting comparability during the period). The company uses this measure to assess the operating results and performance of its segments, perform analytical comparisons, identify strategies to improve performance, and allocate resources to each segment. Management believes that the presentation of adjusted EBIT excluding these items is useful to investors to assess operating performance on a consistent basis by removing the impact of the items that management believes do not directly reflect the performance of each segment's underlying operations. However, adjusted EBIT may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 9 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

• The reconciliation tables below refer to the equivalent GAAP measures adjusted as applicable for the following items:

**Divestiture of Better Health Vitamins, Minerals and Supplements Business**

As previously disclosed in the first quarter of fiscal year 2025, the company completed the divestiture of its Better Health VMS business in its entirety. The divested business included the Natural Vitality, NeoCell, Rainbow Light and RenewLife brands, relevant trademarks and licenses, and associated manufacturing and distribution facilities in Sunrise, Florida. The transaction is in support of the company's IGNITE strategy and reflects the commitment to continue evolving its portfolio to reduce volatility and accelerate sales growth, as well as structurally improve its margin, in service of driving more consistent and profitable growth over time.

Due to the nature, scope and magnitude of this charge, the company's management believes presenting this charge as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period over period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.

**Cyberattack costs** 

As previously disclosed, incremental costs were incurred by the company as the result of the August 2023 cyberattack. These costs related primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating costs from the resulting disruption to the company's business operations. The company has since received insurance recoveries of $100 million related to the cyberattack. No additional insurance recoveries related to the cyberattack are anticipated. Costs associated with ongoing cybersecurity monitoring and prevention as well as enhancement to the company's cybersecurity program are not included within this adjustment.

Due to the nature, scope and magnitude of these costs and recoveries, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period over period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.

**Digital Capabilities and Productivity Enhancements Investment**

As announced in August 2021, the company plans to invest in transformative technologies and processes over a five-year period. This investment began in fiscal year 2022, and includes replacement of the company's enterprise resource planning system and transitioning to a cloud-based platform as well as the implementation of a suite of other digital technologies. The total incremental transformational investment is expected to be $570 to $580 million. It is expected that these implementations will generate efficiencies and transform the company's operations in the areas of supply chain, digital commerce, innovation, brand building and more over the long term.

Of the total investment, approximately 75% is expected to represent incremental operating costs primarily recorded within selling and administrative expenses to be adjusted from reported EPS for purposes of disclosing adjusted EPS through fiscal year 2026, compared to the previous estimate of 70%. About 70% of these operating costs are expected to be related to the implementation of the ERP, with the remaining costs primarily related to the implementation of complementary technologies.

Due to the nature, scope and magnitude of this investment, these costs are considered by management to represent incremental transformational costs above the historical normal level of spending for information technology to support operations. Since these strategic investments, including incremental operating costs, will cease at the end of the investment period, are not expected to recur in the foreseeable future and are not considered representative of the company's underlying operating performance, the company's management believes presenting these costs as an adjustment in the non-GAAP results provides additional information to investors about trends in the company's operations and is useful for period-over-period comparisons. It also allows investors to view underlying operating results in the same manner as they are viewed by company management.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 10 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

The following tables provide reconciliations of organic sales growth/(decrease) (non-GAAP) to net sales growth/(decrease), the most comparable GAAP measure:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** |
| | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** |
| | **Health and Wellness** | **Household** | **Lifestyle** | **International** | **Total Company** <sup>(1)</sup> |
| Net sales growth / (decrease) (GAAP) | 14% | 7% | 3% | (1)% | 4% |
| Add: Foreign Exchange |  |  |  | 2 |  |
| Add/(Subtract): Divestitures/Acquisitions <sup>(2)</sup> |  |  |  |  | 4 |
| Organic sales growth / (decrease) (non-GAAP) | 14% | 7% | 3% | 1% | 8% |
|  | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** |
|  | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** |
|  | **Health and Wellness** | **Household** | **Lifestyle** | **International** | **Total Company** <sup>(1)</sup> |
| Net sales growth / (decrease) (GAAP) | 9% | 3% | 2% | (8)% | 0% |
| Add: Foreign Exchange |  |  |  | 2 |  |
| Add/(Subtract): Divestitures/Acquisitions <sup>(2)</sup> |  |  |  | 11 | 5 |
| Organic sales growth / (decrease) (non-GAAP) | 9% | 3% | 2% | 5% | 5% |

---

<sup>(1)</sup> Total Company includes Corporate and Other. Corporate and Other includes the results of the Better Health VMS business through the date of divestiture.

<sup>(2)</sup> The divestiture impact is calculated as net sales from the Argentina and Better Health VMS businesses after the respective sale dates in the three and twelve month year-ago periods.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 11 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

The following tables provide reconciliations of adjusted diluted earnings per share (non-GAAP) to diluted earnings per share, the most comparable GAAP measure, and adjusted effective tax rate (non-GAAP) to effective tax rate, the most comparable GAAP measure:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Adjusted Diluted Earnings Per Share (EPS) and Adjusted Effective Tax Rate (ETR)** | **Adjusted Diluted Earnings Per Share (EPS) and Adjusted Effective Tax Rate (ETR)** | **Adjusted Diluted Earnings Per Share (EPS) and Adjusted Effective Tax Rate (ETR)** | **Adjusted Diluted Earnings Per Share (EPS) and Adjusted Effective Tax Rate (ETR)** | | |
| *(Dollars in millions except per share data)* | *(Dollars in millions except per share data)* |  |  |  |  |
|  | **Diluted earnings per share** | **Diluted earnings per share** | **Diluted earnings per share** | **Effective tax rate** | **Effective tax rate** |
|  | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
|  | **6/30/2025** | **6/30/2024** | **% Change** | **6/30/2025** | **6/30/2024** |
| As reported (GAAP) | $2.68 | $1.73 | 55% | 18.2% | 19.7% |
| Cyberattack costs, net of insurance recoveries <sup>(1)</sup> |  | (0.17) |  |  | (0.3)% |
| Streamlined operating model <sup>(2)</sup> |  | 0.12 |  |  | 0.2% |
| Digital capabilities and productivity enhancements investment <sup>(3)</sup> | 0.19 | 0.14 |  | 0.4% | 0.3% |
| As adjusted (Non-GAAP) | $2.87 | $1.82 | 58% | 18.6% | 19.9% |
|  | **Diluted earnings per share** | **Diluted earnings per share** | **Diluted earnings per share** | **Effective tax rate** | **Effective tax rate** |
|  | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** |
|  | **6/30/2025** | **6/30/2024** | **% Change** | **6/30/2025** | **6/30/2024** |
| As reported (GAAP) | $6.52 | $2.25 | 190% | 23.6% | 26.5% |
| Loss on divestiture <sup>(4)</sup> | 0.94 | 1.85 |  | (2.3)% | (8.6)% |
| Pension settlement charge <sup>(5)</sup> |  | 1.04 |  |  | 0.9% |
| Cyberattack costs, net of insurance recoveries <sup>(1)</sup> | (0.42) | 0.17 |  | (0.1)% | 0.2% |
| Streamlined operating model <sup>(2)</sup> |  | 0.20 |  |  | 0.2% |
| Digital capabilities and productivity enhancements investment <sup>(3)</sup> | 0.68 | 0.66 |  | 0.2% | 0.9% |
| As adjusted (Non-GAAP) | $7.72 | $6.17 | 25% | 21.4% | 20.1% |
| &nbsp;&nbsp;&nbsp;<sup>(1)</sup>During the three months ended Jun. 30, 2024, the company recognized approximately $28 ($21 after tax) of insurance recoveries related to the cyberattack, net of incremental costs incurred. During the twelve months ended Jun. 30, 2025, the company recognized approximately $70 ($53 after tax) of insurance recoveries related to the cyberattack. In the twelve months ended Jun. 30, 2024, the company incurred approximately $29 ($22 after tax) of costs related to the cyberattack, net of insurance recoveries. Costs related primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating expenses from the resulting disruption to the company's business operations.  | &nbsp;&nbsp;&nbsp;<sup>(1)</sup>During the three months ended Jun. 30, 2024, the company recognized approximately $28 ($21 after tax) of insurance recoveries related to the cyberattack, net of incremental costs incurred. During the twelve months ended Jun. 30, 2025, the company recognized approximately $70 ($53 after tax) of insurance recoveries related to the cyberattack. In the twelve months ended Jun. 30, 2024, the company incurred approximately $29 ($22 after tax) of costs related to the cyberattack, net of insurance recoveries. Costs related primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating expenses from the resulting disruption to the company's business operations.  | &nbsp;&nbsp;&nbsp;<sup>(1)</sup>During the three months ended Jun. 30, 2024, the company recognized approximately $28 ($21 after tax) of insurance recoveries related to the cyberattack, net of incremental costs incurred. During the twelve months ended Jun. 30, 2025, the company recognized approximately $70 ($53 after tax) of insurance recoveries related to the cyberattack. In the twelve months ended Jun. 30, 2024, the company incurred approximately $29 ($22 after tax) of costs related to the cyberattack, net of insurance recoveries. Costs related primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating expenses from the resulting disruption to the company's business operations.  | &nbsp;&nbsp;&nbsp;<sup>(1)</sup>During the three months ended Jun. 30, 2024, the company recognized approximately $28 ($21 after tax) of insurance recoveries related to the cyberattack, net of incremental costs incurred. During the twelve months ended Jun. 30, 2025, the company recognized approximately $70 ($53 after tax) of insurance recoveries related to the cyberattack. In the twelve months ended Jun. 30, 2024, the company incurred approximately $29 ($22 after tax) of costs related to the cyberattack, net of insurance recoveries. Costs related primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating expenses from the resulting disruption to the company's business operations.  | &nbsp;&nbsp;&nbsp;<sup>(1)</sup>During the three months ended Jun. 30, 2024, the company recognized approximately $28 ($21 after tax) of insurance recoveries related to the cyberattack, net of incremental costs incurred. During the twelve months ended Jun. 30, 2025, the company recognized approximately $70 ($53 after tax) of insurance recoveries related to the cyberattack. In the twelve months ended Jun. 30, 2024, the company incurred approximately $29 ($22 after tax) of costs related to the cyberattack, net of insurance recoveries. Costs related primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating expenses from the resulting disruption to the company's business operations.  | &nbsp;&nbsp;&nbsp;<sup>(1)</sup>During the three months ended Jun. 30, 2024, the company recognized approximately $28 ($21 after tax) of insurance recoveries related to the cyberattack, net of incremental costs incurred. During the twelve months ended Jun. 30, 2025, the company recognized approximately $70 ($53 after tax) of insurance recoveries related to the cyberattack. In the twelve months ended Jun. 30, 2024, the company incurred approximately $29 ($22 after tax) of costs related to the cyberattack, net of insurance recoveries. Costs related primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating expenses from the resulting disruption to the company's business operations.  |
| &nbsp;&nbsp;&nbsp;<sup>(2)</sup>During the three and twelve months ended Jun. 30, 2024, the company incurred approximately $19 ($15 after tax) and $32 ($25 after tax), of restructuring and related costs, net for implementation of the streamlined operating model. | &nbsp;&nbsp;&nbsp;<sup>(2)</sup>During the three and twelve months ended Jun. 30, 2024, the company incurred approximately $19 ($15 after tax) and $32 ($25 after tax), of restructuring and related costs, net for implementation of the streamlined operating model. | &nbsp;&nbsp;&nbsp;<sup>(2)</sup>During the three and twelve months ended Jun. 30, 2024, the company incurred approximately $19 ($15 after tax) and $32 ($25 after tax), of restructuring and related costs, net for implementation of the streamlined operating model. | &nbsp;&nbsp;&nbsp;<sup>(2)</sup>During the three and twelve months ended Jun. 30, 2024, the company incurred approximately $19 ($15 after tax) and $32 ($25 after tax), of restructuring and related costs, net for implementation of the streamlined operating model. | &nbsp;&nbsp;&nbsp;<sup>(2)</sup>During the three and twelve months ended Jun. 30, 2024, the company incurred approximately $19 ($15 after tax) and $32 ($25 after tax), of restructuring and related costs, net for implementation of the streamlined operating model. | &nbsp;&nbsp;&nbsp;<sup>(2)</sup>During the three and twelve months ended Jun. 30, 2024, the company incurred approximately $19 ($15 after tax) and $32 ($25 after tax), of restructuring and related costs, net for implementation of the streamlined operating model. |
| &nbsp;&nbsp;&nbsp;<sup>(3)</sup>During the three and twelve months ended Jun. 30, 2025, the company incurred approximately $30 ($23 after tax) and $111 ($85 after tax), respectively and during the three and twelve months ended Jun. 30, 2024, the company incurred approximately $23 ($18 after tax) and $108 ($82 after tax), respectively, of operating expenses related to its digital capabilities and productivity enhancements investment. The expenses relate to the following: | &nbsp;&nbsp;&nbsp;<sup>(3)</sup>During the three and twelve months ended Jun. 30, 2025, the company incurred approximately $30 ($23 after tax) and $111 ($85 after tax), respectively and during the three and twelve months ended Jun. 30, 2024, the company incurred approximately $23 ($18 after tax) and $108 ($82 after tax), respectively, of operating expenses related to its digital capabilities and productivity enhancements investment. The expenses relate to the following: | &nbsp;&nbsp;&nbsp;<sup>(3)</sup>During the three and twelve months ended Jun. 30, 2025, the company incurred approximately $30 ($23 after tax) and $111 ($85 after tax), respectively and during the three and twelve months ended Jun. 30, 2024, the company incurred approximately $23 ($18 after tax) and $108 ($82 after tax), respectively, of operating expenses related to its digital capabilities and productivity enhancements investment. The expenses relate to the following: | &nbsp;&nbsp;&nbsp;<sup>(3)</sup>During the three and twelve months ended Jun. 30, 2025, the company incurred approximately $30 ($23 after tax) and $111 ($85 after tax), respectively and during the three and twelve months ended Jun. 30, 2024, the company incurred approximately $23 ($18 after tax) and $108 ($82 after tax), respectively, of operating expenses related to its digital capabilities and productivity enhancements investment. The expenses relate to the following: | &nbsp;&nbsp;&nbsp;<sup>(3)</sup>During the three and twelve months ended Jun. 30, 2025, the company incurred approximately $30 ($23 after tax) and $111 ($85 after tax), respectively and during the three and twelve months ended Jun. 30, 2024, the company incurred approximately $23 ($18 after tax) and $108 ($82 after tax), respectively, of operating expenses related to its digital capabilities and productivity enhancements investment. The expenses relate to the following: | &nbsp;&nbsp;&nbsp;<sup>(3)</sup>During the three and twelve months ended Jun. 30, 2025, the company incurred approximately $30 ($23 after tax) and $111 ($85 after tax), respectively and during the three and twelve months ended Jun. 30, 2024, the company incurred approximately $23 ($18 after tax) and $108 ($82 after tax), respectively, of operating expenses related to its digital capabilities and productivity enhancements investment. The expenses relate to the following: |
|  | **Three months ended** | **Three months ended** | **Twelve months ended** | **Twelve months ended** |  |
|  | **6/30/2025** | **6/30/2024** | **6/30/2025** | **6/30/2024** |  |
| External consulting fees <sup>(a)</sup> | $22 | $15 | $78 | $80 |  |
| IT project personnel costs <sup>(b)</sup> | 2 | 2 | 7 | 8 |  |
| Other <sup>(c)</sup> | 6 | 6 | 26 | 20 |  |
| Total | $30 | $23 | $111 | $108 |  |
| &nbsp;&nbsp;&nbsp;<sup>(a)</sup>Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this transformative investment. The company relies on consultants for certain capabilities required for these programs that the company does not maintain internally. These costs support the implementation of these programs incremental to the company's normal IT costs and will not be incurred following implementation.  | &nbsp;&nbsp;&nbsp;<sup>(a)</sup>Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this transformative investment. The company relies on consultants for certain capabilities required for these programs that the company does not maintain internally. These costs support the implementation of these programs incremental to the company's normal IT costs and will not be incurred following implementation.  | &nbsp;&nbsp;&nbsp;<sup>(a)</sup>Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this transformative investment. The company relies on consultants for certain capabilities required for these programs that the company does not maintain internally. These costs support the implementation of these programs incremental to the company's normal IT costs and will not be incurred following implementation.  | &nbsp;&nbsp;&nbsp;<sup>(a)</sup>Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this transformative investment. The company relies on consultants for certain capabilities required for these programs that the company does not maintain internally. These costs support the implementation of these programs incremental to the company's normal IT costs and will not be incurred following implementation.  | &nbsp;&nbsp;&nbsp;<sup>(a)</sup>Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this transformative investment. The company relies on consultants for certain capabilities required for these programs that the company does not maintain internally. These costs support the implementation of these programs incremental to the company's normal IT costs and will not be incurred following implementation.  | &nbsp;&nbsp;&nbsp;<sup>(a)</sup>Comprised of third-party consulting fees incurred to assist in the project management and the preliminary project stage of this transformative investment. The company relies on consultants for certain capabilities required for these programs that the company does not maintain internally. These costs support the implementation of these programs incremental to the company's normal IT costs and will not be incurred following implementation.  |
| &nbsp;&nbsp;&nbsp;<sup>(b)</sup>Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the company considers these costs not reflective of the ongoing costs to operate its business. | &nbsp;&nbsp;&nbsp;<sup>(b)</sup>Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the company considers these costs not reflective of the ongoing costs to operate its business. | &nbsp;&nbsp;&nbsp;<sup>(b)</sup>Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the company considers these costs not reflective of the ongoing costs to operate its business. | &nbsp;&nbsp;&nbsp;<sup>(b)</sup>Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the company considers these costs not reflective of the ongoing costs to operate its business. | &nbsp;&nbsp;&nbsp;<sup>(b)</sup>Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the company considers these costs not reflective of the ongoing costs to operate its business. | &nbsp;&nbsp;&nbsp;<sup>(b)</sup>Comprised of labor costs associated with internal IT project management teams that are utilized to oversee the new system implementations. Given the magnitude and transformative nature of the implementations planned, the necessary project management costs are incremental to the historical levels of spend and will no longer be incurred subsequent to implementation. As a result of this long-term strategic investment, the company considers these costs not reflective of the ongoing costs to operate its business. |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 12 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;<sup>(c)</sup>Comprised of various other expenses associated with the company's new system implementations, including company personnel dedicated to the project that have been backfilled with either permanent or temporary resources in positions that are considered part of normal operating expenses. | &nbsp;&nbsp;&nbsp;<sup>(c)</sup>Comprised of various other expenses associated with the company's new system implementations, including company personnel dedicated to the project that have been backfilled with either permanent or temporary resources in positions that are considered part of normal operating expenses. | &nbsp;&nbsp;&nbsp;<sup>(c)</sup>Comprised of various other expenses associated with the company's new system implementations, including company personnel dedicated to the project that have been backfilled with either permanent or temporary resources in positions that are considered part of normal operating expenses. |
| &nbsp;&nbsp;&nbsp;<sup>(4)</sup>During the twelve months ended Jun. 30, 2025, the company incurred an after tax charge of $118 related to the divestiture of the Better Health VMS business. During the twelve months ended Jun. 30, 2024, the company incurred approximately $240 ($231 after tax) of costs related to the divestiture of the Argentina business.  | &nbsp;&nbsp;&nbsp;<sup>(4)</sup>During the twelve months ended Jun. 30, 2025, the company incurred an after tax charge of $118 related to the divestiture of the Better Health VMS business. During the twelve months ended Jun. 30, 2024, the company incurred approximately $240 ($231 after tax) of costs related to the divestiture of the Argentina business.  | &nbsp;&nbsp;&nbsp;<sup>(4)</sup>During the twelve months ended Jun. 30, 2025, the company incurred an after tax charge of $118 related to the divestiture of the Better Health VMS business. During the twelve months ended Jun. 30, 2024, the company incurred approximately $240 ($231 after tax) of costs related to the divestiture of the Argentina business.  |
| &nbsp;&nbsp;&nbsp;<sup>(5)</sup>During the twelve months ended Jun. 30, 2024, the company incurred approximately $171 ($130 after tax) of costs related to the settlement of the domestic qualified pension plan.  | &nbsp;&nbsp;&nbsp;<sup>(5)</sup>During the twelve months ended Jun. 30, 2024, the company incurred approximately $171 ($130 after tax) of costs related to the settlement of the domestic qualified pension plan.  | &nbsp;&nbsp;&nbsp;<sup>(5)</sup>During the twelve months ended Jun. 30, 2024, the company incurred approximately $171 ($130 after tax) of costs related to the settlement of the domestic qualified pension plan.  |
|  | **Full year 2026 outlook (estimated range)** | **Full year 2026 outlook (estimated range)** |
|  | **Diluted earnings per share** | **Diluted earnings per share** |
|  | **Low** | **High** |
| As estimated (GAAP) | $5.60 | $5.95 |
| Digital capabilities and productivity enhancements investment <sup>(6)</sup> | 0.35 | 0.35 |
| As adjusted (Non-GAAP) | $5.95 | $6.30 |
| &nbsp;&nbsp;&nbsp;<sup>(6)</sup>In fiscal year 2026, the company expects to incur approximately $50-$60 ($38-$46 after tax) of operating expenses related to its digital capabilities and productivity enhancements investment. | &nbsp;&nbsp;&nbsp;<sup>(6)</sup>In fiscal year 2026, the company expects to incur approximately $50-$60 ($38-$46 after tax) of operating expenses related to its digital capabilities and productivity enhancements investment. | &nbsp;&nbsp;&nbsp;<sup>(6)</sup>In fiscal year 2026, the company expects to incur approximately $50-$60 ($38-$46 after tax) of operating expenses related to its digital capabilities and productivity enhancements investment. |

---

The following tables provide reconciliations of adjusted EBIT (non-GAAP) to earnings (losses) before income taxes, the most comparable GAAP measure:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Reconciliation of earnings (losses) before income taxes to adjusted EBIT** | **Reconciliation of earnings (losses) before income taxes to adjusted EBIT** | **Reconciliation of earnings (losses) before income taxes to adjusted EBIT** | **Reconciliation of earnings (losses) before income taxes to adjusted EBIT** |
| | **Three months ended** | **Three months ended** | **Twelve months ended** | **Twelve months ended** |
| | **6/30/2025** | **6/30/2024** | **6/30/2025** | **6/30/2024** |
| Earnings (losses) before income taxes | $410 | $275 | $1078 | $398 |
| &nbsp;&nbsp;&nbsp;Interest income | (2) | (2) | (9) | (23) |
| &nbsp;&nbsp;&nbsp;Interest expense | 22 | 21 | 88 | 90 |
| &nbsp;&nbsp;Loss on divestiture |  |  | 118 | 240 |
| &nbsp;&nbsp;Pension settlement charge |  |  |  | 171 |
| &nbsp;&nbsp;Cyberattack costs, net of insurance recoveries |  | (28) | (70) | 29 |
| &nbsp;&nbsp;Streamlined operating model  |  | 19 |  | 32 |
| &nbsp;&nbsp;Digital capabilities and productivity enhancements investment | 30 | 23 | 111 | 108 |
| Adjusted EBIT | $460 | $308 | $1316 | $1045 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 13 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Condensed Consolidated Statements of Earnings** | **Condensed Consolidated Statements of Earnings** | | | |
| Dollars in millions, except per share data |  |  |  |  |
|  | **Three months ended** | **Three months ended** | **Twelve months ended** | **Twelve months ended** |
|  | **06/30/2025** | **06/30/2024** | **06/30/2025** | **06/30/2024** |
|  | (Unaudited) | (Unaudited) | (Unaudited) |  |
| Net sales | $1988 | $1903 | $7104 | $7093 |
| Cost of products sold | 1064 | 1019 | 3891 | 4045 |
| Gross profit | 924 | 884 | 3213 | 3048 |
| Selling and administrative expenses | 296 | 268 | 1124 | 1167 |
| Advertising costs | 171 | 266 | 770 | 832 |
| Research and development costs | 32 | 33 | 121 | 126 |
| Loss on divestiture |  |  | 118 | 240 |
| Pension settlement charge |  |  |  | 171 |
| Interest expense | 22 | 21 | 88 | 90 |
| Other (income) expense, net | (7) | 21 | (86) | 24 |
| Earnings before income taxes | 410 | 275 | 1078 | 398 |
| Income taxes | 74 | 54 | 254 | 106 |
| Net earnings | 336 | 221 | 824 | 292 |
| Less: Net earnings attributable to noncontrolling interests | 4 | 5 | 14 | 12 |
| Net earnings attributable to Clorox | $332 | $216 | $810 | $280 |
| Net earnings per share attributable to Clorox |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic net earnings per share | $2.70 | $1.74 | $6.56 | $2.26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted net earnings per share | $2.68 | $1.73 | $6.52 | $2.25 |
| Weighted average shares outstanding (in thousands) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 123173 | 124300 | 123525 | 124174 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 123744 | 125052 | 124287 | 124804 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 14 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Reportable Segment Information** | **Reportable Segment Information** | **Reportable Segment Information** | | | | |
| **(Unaudited)** | | | | | | |
| Dollars in millions |  |  |  |  |  |  |
|  | **Net sales** | **Net sales** | **Net sales** | **Net sales** | **Net sales** | **Net sales** |
|  | **Three months ended** | **Three months ended** | **Three months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** |
|  | **6/30/2025** | **6/30/2024** | **% Change**<sup>(1)</sup> | **6/30/2025** | **6/30/2024** | **% Change**<sup>(1)</sup> |
| Health and Wellness  | $741 | $652 | 14% | $2697 | $2485 | 9% |
| Household | 639 | 597 | 7% | 2001 | 1950 | 3% |
| Lifestyle | 339 | 328 | 3% | 1303 | 1275 | 2% |
| International | 269 | 271 | (1)% | 1065 | 1162 | (8)% |
| &nbsp;&nbsp;Reportable segment total | $1988 | $1848 |  | $7066 | $6872 |  |
| Corporate and Other <sup>(2)</sup> |  | 55 | (100)% | 38 | 221 | (83)% |
| Total | $1988 | $1903 | 4% | $7104 | $7093 | —% |
|  | **Segment adjusted EBIT** | **Segment adjusted EBIT** | **Segment adjusted EBIT** | **Segment adjusted EBIT** | **Segment adjusted EBIT** | **Segment adjusted EBIT** |
|  | **Three months ended** | **Three months ended** | **Three months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** |
|  | **6/30/2025** | **6/30/2024** | **% Change**<sup>(1)</sup> | **6/30/2025** | **6/30/2024** | **% Change**<sup>(1)</sup> |
| Health and Wellness  | $243 | $202 | 20% | $840 | $719 | 17% |
| Household | 156 | 98 | 59% | 325 | 260 | 25% |
| Lifestyle | 94 | 61 | 54% | 290 | 253 | 15% |
| International | 23 | 18 | 28% | 110 | 122 | (10)% |
| &nbsp;&nbsp;Reportable segment total | $516 | $379 |  | $1565 | $1354 |  |
| Corporate and Other <sup>(2)</sup> | (56) | (71) |  | (249) | (309) |  |
| Interest income | 2 | 2 |  | 9 | 23 |  |
| Interest expense | (22) | (21) |  | (88) | (90) |  |
| Loss on divestiture <sup>(3)</sup> |  |  |  | (118) | (240) |  |
| Pension settlement <sup>(4)</sup> |  |  |  |  | (171) |  |
| Cyberattack costs, net of insurance recoveries <sup>(5)</sup> |  | 28 |  | 70 | (29) |  |
| Streamlined operating model <sup>(6)</sup> |  | (19) |  |  | (32) |  |
| Digital capabilities and productivity enhancements investment <sup>(7)</sup> | (30) | (23) |  | (111) | (108) |  |
| Earnings (losses) before income taxes | $410 | $275 | 49% | $1078 | $398 | 171% |

---

<sup>(1)</sup> Percentages based on rounded numbers.

<sup>(2)</sup> Corporate and Other includes the Better Health VMS business.

<sup>(3)</sup> Represents the loss on divestiture of the Better Health VMS business of $118 after tax for the twelve months ended Jun. 30, 2025, and the loss on divestiture of the Argentina business of $240 ($231 after tax) for the twelve months ended Jun. 30, 2024.

<sup>(4)</sup> Represents the pension settlement charge of $171 ($130 after tax) for the twelve months ended Jun. 30, 2024.

<sup>(5)</sup> Represents insurance recoveries related to the cyberattack, net of costs incurred of $28 ($21 after tax) for the three months ended Jun. 30, 2024. Represents insurance recoveries related to the cyberattack of approximately $70 ($53 after tax) for the twelve months ended Jun. 30, 2025, and incurred costs related to the cyberattack, net of insurance recoveries of $29 ($22 after tax) for the twelve months ended Jun. 30, 2024.

<sup>(6)</sup> Represents restructuring and related costs, net for implementation of the streamlined operating model of $19 ($15 after tax) and $32 ($25 after tax) for the three and twelve months ended Jun. 30, 2024, respectively.

<sup>(7)</sup> Represents expenses related to the company's digital capabilities and productivity enhancements investment of $30 ($23 after tax) and $111 ($85 after tax) for the three and twelve months ended Jun. 30, 2025, respectively, and $23 ($18 after tax) and $108 ($82 after tax) for the three and twelve months ended June 30, 2024, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 15 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

------

---

| | | |
|:---|:---|:---|
| **Condensed Consolidated Balance Sheets** | | |
| Dollars in millions |  |  |
|  | **6/30/2025** | **6/30/2024** |
|  | **(Unaudited)** |  |
| **ASSETS** |  |  |
| Current assets |  |  |
| Cash and cash equivalents | $167 | $202 |
| Receivables, net | 821 | 695 |
| Inventories, net | 523 | 637 |
| Prepaid expenses and other current assets | 97 | 88 |
| Total current assets | 1608 | 1622 |
| Property, plant and equipment, net | 1267 | 1315 |
| Operating lease right-of-use assets | 333 | 360 |
| Goodwill | 1229 | 1228 |
| Trademarks, net | 502 | 538 |
| Other intangible assets, net | 64 | 143 |
| Other assets | 558 | 545 |
| Total assets | $5561 | $5751 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current liabilities |  |  |
| Notes and loans payable | $4 | $4 |
| Current operating lease liabilities | 87 | 84 |
| Accounts payable and accrued liabilities | 1828 | 1486 |
| Total current liabilities | 1919 | 1574 |
| Long-term debt | 2484 | 2481 |
| Long-term operating lease liabilities | 305 | 334 |
| Other liabilities | 351 | 848 |
| Deferred income taxes | 20 | 22 |
| Total liabilities | 5079 | 5259 |
| Commitments and contingencies |  |  |
| Stockholders' equity |  |  |
| Preferred stock |  |  |
| Common stock | 131 | 131 |
| Additional paid-in capital | 1319 | 1288 |
| Retained earnings | 432 | 250 |
| Treasury stock | (1404) | (1186) |
| Accumulated other comprehensive net (loss) income | (157) | (155) |
| Total Clorox stockholders' equity | 321 | 328 |
| Noncontrolling interests | 161 | 164 |
| Total stockholders' equity | 482 | 492 |
| Total liabilities and stockholders' equity | $5561 | $5751 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Page 16 of [16](#i5f1323e19ca2491fb365e6974f91b623_46)

## Exhibit 99.2

---

| | |
|:---|:---|
| The Clorox Company | ![image_12a.jpg](image_12a.jpg) |

---

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** |
| **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** |
| | **Reported**<br>**(GAAP)**<br>**Net Sales**<br>**Growth/ (Decrease)** | **Reported Volume** | **Acquisitions & Divestitures** <sup>(1)</sup> | **Foreign Exchange Impact** | **Price**<br>**Mix and**<br>**Other** <sup>(2)</sup> | **Organic**<br>**Sales**<br>**Growth/ (Decrease)**<br>**(Non-GAAP)** <sup>(3)</sup> | **Organic**<br>**Volume** <sup>(4)</sup> |
| &nbsp;&nbsp;Health and Wellness | 14% | 18% | —% | —% | (4)% | 14% | 18% |
| &nbsp;&nbsp;Household | 7 | 13 |  |  | (6) | 7 | 13 |
| &nbsp;&nbsp;Lifestyle | 3 | 8 |  |  | (5) | 3 | 8 |
| International <sup>(4)</sup> | (1) | 5 |  | (2) | (4) | 1 | 5 |
| **Total Company** <sup>(4)(5)</sup> | **4%** | **8%** | **(4)%** | **—%** | **(4)%** | **8%** | **12%** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** |
| **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** |
| | **Reported**<br>**(GAAP)**<br>**Net Sales**<br>**Growth/ (Decrease)** | **Reported Volume** | **Acquisitions & Divestitures** <sup>(1)</sup> | **Foreign Exchange Impact** | **Price**<br>**Mix and**<br>**Other** <sup>(2)</sup> | **Organic**<br>**Sales**<br>**Growth/ (Decrease)**<br>**(Non-GAAP)** <sup>(3)</sup> | **Organic**<br>**Volume** <sup>(4)</sup> |
| &nbsp;&nbsp;Health and Wellness | 9% | 11% | —% | —% | (2)% | 9% | 11% |
| &nbsp;&nbsp;Household | 3 | 6 |  |  | (3) | 3 | 6 |
| &nbsp;&nbsp;Lifestyle | 2 | 4 |  |  | (2) | 2 | 4 |
| International <sup>(4)</sup> | (8) | (8) | (11) | (2) | 2 | 5 | 6 |
| **Total Company** <sup>(4)(5)</sup> | **—%** | **1%** | **(5)%** | **—%** | **(1)%** | **5%** | **7%** |

---

<sup>(1)</sup> The divestiture impact is calculated as net sales from the Argentina and Better Health Vitamins, Minerals and Supplements (VMS) businesses after the respective sale dates in the three and twelve month year-ago periods.

<sup>(2)</sup> This represents the net impact on net sales growth / (decrease) from pricing actions, mix, trade promotion spending, mix from acquisitions and divestitures and other factors. In the three months ended Jun. 30, 2025, the impact from divestiture mix was 0% for both International and Total Company. In the twelve months ended Jun. 30, 2025, the impact from divestiture mix was 3% and 1% for International and Total Company, respectively.

<sup>(3)</sup> Organic sales growth/ (decrease) is defined as net sales growth / (decrease) excluding the effect of any acquisitions and divestitures and foreign exchange rate changes. See "Non-GAAP Financial Information" below for reconciliation of organic sales growth/ (decrease) to net sales growth/ (decrease), the most directly comparable GAAP financial information.

Management believes that the presentation of organic sales growth / (decrease) is useful to investors because it excludes sales from any acquisitions and divestitures, which results in a comparison of sales only from the businesses that the company was operating throughout the relevant periods, and the impact of foreign exchange rate changes, which are out of the control of the company and management. However, organic sales growth / (decrease) may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded.

<sup>(4)</sup> Organic volume represents volume excluding the effect of any acquisitions and divestitures. In the three months ended Jun. 30, 2025, the volume impact of divestitures was 0% and (4)% for International and Total Company, respectively. In the twelve months ended Jun. 30, 2025, the volume impact of divestitures was (14)% and (6)% for International and Total Company, respectively.

<sup>(5)</sup> Total Company includes Corporate and Other. Corporate and Other includes the results of the Better Health VMS business through the date of divestiture.

------

---

| | |
|:---|:---|
| The Clorox Company | ![image_12a.jpg](image_12a.jpg) |

---

The following table provides a reconciliation of organic sales growth / (decrease) (non-GAAP) to net sales growth / (decrease) (GAAP), the most comparable GAAP measure:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** | **Three months ended Jun. 30, 2025** |
| | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** |
| | **Health and Wellness** | **Household** | **Lifestyle** | **International** | **Total Company** <sup>(1)</sup> |
| Net sales growth / (decrease) (GAAP) | 14% | 7% | 3% | (1)% | 4% |
| Add: Foreign Exchange |  |  |  | 2 |  |
| Add/(Subtract): Divestitures/Acquisitions <sup>(2)</sup> |  |  |  |  | 4 |
| Organic sales growth / (decrease) (non-GAAP) | 14% | 7% | 3% | 1% | 8% |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** | **Twelve months ended Jun. 30, 2025** |
| | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** | **Percentage change versus the year-ago period** |
| | **Health and Wellness** | **Household** | **Lifestyle** | **International** | **Total Company** <sup>(1)</sup> |
| Net sales growth / (decrease) (GAAP) | 9% | 3% | 2% | (8)% | —% |
| Add: Foreign Exchange |  |  |  | 2 |  |
| Add/(Subtract): Divestitures/Acquisitions <sup>(2)</sup> |  |  |  | 11 | 5 |
| Organic sales growth / (decrease) (non-GAAP) | 9% | 3% | 2% | 5% | 5% |

---

<sup>(1)</sup> Total Company includes Corporate and Other. Corporate and Other includes the results of the Better Health VMS business through the date of divestiture.

<sup>(2)</sup> The divestiture impact is calculated as net sales from the Argentina and Better Health VMS businesses after the respective sale dates in the three and twelve month year-ago periods.

------

---

| | |
|:---|:---|
| The Clorox Company | ![image_12a.jpg](image_12a.jpg) |

---

Supplemental Unaudited Condensed Information – <u>Gross Margin Drivers</u>

The table below provides details on the drivers of gross margin change versus the year-ago period.

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Driver** | **Gross Margin Change vs. Prior Year (basis points)**  | **Gross Margin Change vs. Prior Year (basis points)**  | **Gross Margin Change vs. Prior Year (basis points)**  | **Gross Margin Change vs. Prior Year (basis points)**  | **Gross Margin Change vs. Prior Year (basis points)**  | **Gross Margin Change vs. Prior Year (basis points)**  | **Gross Margin Change vs. Prior Year (basis points)**  | **Gross Margin Change vs. Prior Year (basis points)**  | **Gross Margin Change vs. Prior Year (basis points)**  | **Gross Margin Change vs. Prior Year (basis points)**  |
| **Driver** | **FY24** | **FY24** | **FY24** | **FY24** | **FY24** | **FY25** | **FY25** | **FY25** | **FY25** | **FY25** |
| **Driver** | **Q1** | **Q2** | **Q3** | **Q4** | **FY** | **Q1** | **Q2** | **Q3** | **Q4** | **FY** |
| Cost Savings | +220 | +170 | +140 | +170 | +180 | +240 | +170 | +170 | +160 | +190 |
| Price Changes | +470 | +380 | +420 | +10 | +300 | +20 | +10 | +10 | +10 | +10 |
| Market Movement (commodities) | -20 | 0 | -20 | +60 | +10 | +20 | -20 | -40 | -50 | -20 |
| Manufacturing & Logistics  | 0 | +10 | -210 | +190 | +60 | -10 | -30 | +40 | -170 | -40 |
| All other <sup>(1) (2) (3) (4) (5)</sup> | -430 | +170 | -290 | -50 | -190 | +470 | -100 | +60 | +50 | +80 |
| **Change vs prior year** | **+240** | **+730** | **+40** | **+380** | **+360** | **+740** | **+30** | **+240** | **0** | **+220** |
| *Gross Margin (%)* | *38.4%* | *43.5%* | *42.2%* | *46.5%* | *43.0%* | *45.8%* | *43.8%* | *44.6%* | *46.5%* | *45.2%* |

---

<sup>(1)</sup> In Q1 of fiscal year 2024, "All other" includes the impact from lower shipment volumes and mix and assortment.

<sup>(2)</sup> In Q2 of fiscal year 2024, "All other" includes the positive impact from higher shipment volumes and the negative impact from foreign exchange.

<sup>(3)</sup> In Q3 of fiscal year 2024, "All other" includes the negative impact from foreign exchange and higher trade promotion spending.

<sup>(4)</sup> In Q1 of fiscal year 2025, "All other" includes the positive impact from higher shipment volumes.

<sup>(5)</sup> In Q2 of fiscal year 2025, "All other" includes the negative impact from lower shipment volumes

------

---

| | |
|:---|:---|
| The Clorox Company | ![image_12a.jpg](image_12a.jpg) |

---

Supplemental Unaudited Condensed Information – <u>Cash Flow</u>

*For the quarter ended Jun. 30, 2025*

**Capital expenditures for the fourth quarter were $75 million versus $81 million in the year-ago quarter (Fiscal year 2025 = $220 million).**

Depreciation and amortization expense for the fourth quarter was $57 million versus $59 million in the year-ago quarter (Fiscal year 2025 = $219 million).

**Net cash provided by operations in the fourth quarter was $294 million, or 14.8% of net sales (Fiscal year 2025 = $981 million, or 13.8% of net sales).** 

Supplemental Unaudited Condensed Information – <u>Free Cash Flow</u> 

Fiscal Year Free Cash Flow Reconciliation

*Dollars in Millions and percentages based on rounded numbers*

---

| | | |
|:---|:---|:---|
| | <br>**Fiscal** <br>**year**<br>**2025** | <br>**Fiscal** <br>**year**<br> **2024** |
| **Net cash provided by operations – GAAP** | **$981** | **$695** |
| Less: Capital expenditures | $220 | $212 |
| **Free cash flow – non-GAAP** <sup>(1)</sup> | **$761** | **$483** |
| *Free cash flow as a percentage of net sales – non-GAAP* <sup>(1)</sup> | *10.7%* | *6.8%* |
| Net sales | $7104 | $7093 |

---

<sup>(1)</sup> In accordance with the SEC's Regulation G, this schedule provides the definition of certain non-GAAP measures and the reconciliation to the most closely related GAAP measure. Management uses free cash flow and free cash flow as a percentage of net sales to help assess the cash generation ability of the business and funds available for investing activities, such as acquisitions, investing in the business to drive growth and financing activities, including debt payments, dividend payments and stock repurchases. Free cash flow does not represent cash available only for discretionary expenditures since the Company has mandatory debt service requirements and other contractual and non-discretionary expenditures. In addition, free cash flow may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures and should be read in connection with the company's consolidated financial statements presented in accordance with GAAP.

------

---

| | |
|:---|:---|
| The Clorox Company | ![image_12a.jpg](image_12a.jpg) |

---

Supplemental Unaudited Reconciliation of Earnings Before Income Taxes to EBIT <sup>(1)(3)</sup> and Adjusted EBIT <sup>(2)(3)</sup>

*Dollars in millions and percentages based on rounded numbers*

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **FY 2024** | **FY 2024** | **FY 2024** | **FY 2024** | **FY 2024** | **FY 2025** | **FY 2025** | **FY 2025** | **FY 2025** | **FY 2025** |
|  | **Q1**<br>**9/30/23** | **Q2**<br>**12/31/23** | **Q3**<br>**3/31/24** | **Q4**<br>**6/30/24** | **FY**<br>**6/30/24** | **Q1**<br>**9/30/24** | **Q2**<br>**12/31/24** | **Q3**<br>**3/31/25** | **Q4**<br>**6/30/25** | **FY**<br>**6/30/25** |
| **Earnings (losses) before income taxes** | $29 | $136 | ($42) | $275 | $398 | $177 | $237 | $254 | $410 | $1078 |
| &nbsp;&nbsp;Interest income | (10) | (7) | (4) | (2) | (23) | (3) | (2) | (2) | (2) | (9) |
| &nbsp;&nbsp;Interest expense | 21 | 26 | 22 | 21 | 90 | 21 | 22 | 23 | 22 | 88 |
| **EBIT** <sup>(1)(3)</sup> | **$40** | **$155** | **($24)** | **$294** | **$465** | **$195** | **$257** | **$275** | **$430** | **$1157** |
| *EBIT margin* <sup>(1)(3)</sup> | **2.9%** | **7.8%** | **-1.3%** | **15.4%** | **6.6%** | **11.1%** | **15.2%** | **16.5%** | **21.6%** | **16.3%** |
| Loss on divestiture<sup>(4)</sup> |  |  | 240 |  | 240 | 118 |  |  |  | 118 |
| Pension settlement charge <sup>(5)</sup> |  | 171 |  |  | 171 |  |  |  |  |  |
| Cyberattack costs, net of insurance recoveries <sup>(6)</sup> | 24 | 25 | 8 | (28) | 29 | (10) | (25) | (35) |  | (70) |
| Streamlined operating model <sup>(7)</sup> |  | 3 | 10 | 19 | 32 |  |  |  |  |  |
| Digital capabilities and productivity enhancements investment <sup>(8)</sup> | 27 | 32 | 26 | 23 | 108 | 29 | 26 | 26 | 30 | 111 |
| Adjusted EBIT – non-GAAP <sup>(2)(3)</sup> | **$91** | **$386** | **$260** | **$308** | **$1045** | **$332** | **$258** | **$266** | **$460** | **$1316** |
| Adjusted EBIT margin <sup>(2)(3)</sup> | **6.6%** | **19.4%** | **14.3%** | **16.2%** | **14.7%** | **18.8%** | **15.3%** | **15.9%** | **23.1%** | **18.5%** |
| &nbsp;&nbsp;Net sales | $1386 | $1990 | $1814 | $1903 | $7093 | $1762 | $1686 | $1668 | $1988 | $7104 |

---

(1)EBIT (a non-GAAP measure) represents earnings (losses) before income taxes (a GAAP measure), excluding interest income and interest expense, as reported above. EBIT margin is the ratio of EBIT to net sales.

(2)Adjusted EBIT (a non-GAAP measure) represents earnings (losses) before income taxes (a GAAP measure), excluding interest income, interest expense and other significant items that are

nonrecurring or unusual (such as the pension settlement charge, incremental costs and insurance recoveries related to the August 2023 cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions / divestitures and other nonrecurring or unusual items as reported above). Adjusted EBIT margin is the ratio of adjusted EBIT to net sales. Refer to the Non-GAAP Financial Information within the earnings release for further discussion on the adjustments presented.

(3)In accordance with the SEC's Regulation G, this schedule provides the definition of certain non-GAAP measures and the reconciliation to the most closely related GAAP measure. Management believes the presentation of EBIT, EBIT margin, adjusted EBIT and adjusted EBIT margin provides useful additional information to investors about trends in the company's operations and is useful for comparability of performance over time. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read in connection with the company's consolidated financial statements presented in accordance with GAAP.

(4)Represents losses related to the divestitures of the Argentina and Better Health VMS businesses.

(5)Represents costs related to the settlement of the domestic qualified pension plan.

(6)Reflects incremental costs, net of insurance recoveries, related to the cyberattack. These costs relate primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating costs from the resulting disruption to the company's business operations. Refer to the Non-GAAP Financial Information within the earnings release for further discussion.

(7)Reflects the restructuring and related costs, net incurred by the company for implementation of the streamlined operating model. These expenses were primarily attributable to employee-related costs and other associated costs.

(8)Reflects the operating expenses incurred by the company related to its digital capabilities and productivity enhancements investment. The majority of these expenses relate to external consulting fees. The remaining expenses relate to internal IT project management and supporting personnel costs and other costs. Refer to the Non-GAAP Financial Information within the earnings release for further discussion.

------

---

| | |
|:---|:---|
| The Clorox Company | ![image_12a.jpg](image_12a.jpg) |

---

Supplemental Unaudited Reconciliation of Adjusted Earnings Per Share <sup>(7)(9)</sup> and Adjusted Effective Tax Rate <sup>(8)(9)</sup>

(Dollars in millions except per share data)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Diluted earnings per share** | **Diluted earnings per share** | **Diluted earnings per share** | **Effective tax rate** | **Effective tax rate** |
| | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **6/30/2025** | **6/30/2024** | **% Change** | **6/30/2025** | **6/30/2024** |
| As reported (GAAP) | $2.68 | $1.73 | 55% | 18.2% | 19.7% |
| Cyberattack costs, net of insurance recoveries <sup>(1)</sup> |  | (0.17) |  |  | (0.3)% |
| Streamlined operating model <sup>(2)</sup> |  | 0.12 |  |  | 0.2% |
| Digital capabilities and productivity enhancements investment <sup>(3)</sup> | 0.19 | 0.14 |  | 0.4% | 0.3% |
| As adjusted (Non-GAAP) <sup>(7)(8)(9)</sup> | $2.87 | $1.82 | 58% | 18.6% | 19.9% |
|  | **Diluted earnings per share** | **Diluted earnings per share** | **Diluted earnings per share** | **Effective tax rate** | **Effective tax rate** |
|  | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** | **Twelve months ended** |
|  | **6/30/2025** | **6/30/2024** | **% Change** | **6/30/2025** | **6/30/2024** |
| As reported (GAAP) | $6.52 | $2.25 | 190% | 23.6% | 26.5% |
| Loss on divestiture <sup>(4)</sup> | 0.94 | 1.85 |  | (2.3)% | (8.6)% |
| Pension settlement charge <sup>(5)</sup> |  | 1.04 |  |  | 0.9% |
| Cyberattack costs, net of insurance recoveries <sup>(1)</sup> | (0.42) | 0.17 |  | (0.1)% | 0.2% |
| Streamlined operating model <sup>(2)</sup> |  | 0.20 |  |  | 0.2% |
| Digital capabilities and productivity enhancements investment <sup>(3)</sup> | 0.68 | 0.66 |  | 0.2% | 0.9% |
| As adjusted (Non-GAAP) <sup>(7)(8)(9)</sup> | $7.72 | $6.17 | 25% | 21.4% | 20.1% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)During the three months ended Jun. 30, 2024, the company recognized approximately $28 ($21 after tax) of insurance recoveries related to the cyberattack, net of incremental costs incurred. During the twelve months ended Jun. 30, 2025, the company recognized approximately $70 ($53 after tax) of insurance recoveries related to the cyberattack. In the twelve months ended Jun. 30, 2024, the company incurred approximately $29 ($22 after tax) of costs related to the cyberattack, net of insurance recoveries. These costs related primarily to third-party consulting services, including IT recovery and forensic experts and other professional services incurred to investigate and remediate the attack, as well as incremental operating costs from the resulting disruption to the company's business operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)During the three and twelve months ended Jun. 30, 2024, the company incurred approximately $19 ($15 after tax) and $32 ($25 after tax), respectively, of restructuring and related costs, net for implementation of the streamlined operating model.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)During the three and twelve months ended Jun. 30, 2025, the company incurred approximately $30 ($23 after tax) and $111 ($85 after tax), respectively, and during the three and twelve months ended Jun. 30, 2024, the company incurred approximately $23 ($18 after tax) and $108 ($82 after tax), respectively, of operating expenses related to its digital capabilities and productivity enhancements investment. Refer to the Non-GAAP Financial Information within the earnings release for further discussion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)During the twelve months ended Jun. 30, 2025, the company incurred an after tax charge of $118 related to the divestiture of the Better Health VMS business. During the twelve months ended Jun. 30, 2024, the company incurred approximately $240 ($231 after tax) of costs related to the divestiture of the Argentina business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5)During the twelve months ended Jun. 30, 2024, the company incurred approximately $171 ($130 after tax) of costs related to the settlement of the domestic qualified pension plan.

------

---

| | |
|:---|:---|
| The Clorox Company | ![image_12a.jpg](image_12a.jpg) |

---

---

| | | |
|:---|:---|:---|
| | **Full year 2026 outlook** | **Full year 2026 outlook** |
| | **Estimated range** | **Estimated range** |
| | **Diluted earnings per share** | **Diluted earnings per share** |
| | **Low** | **High** |
| As estimated (GAAP) | $5.60 | $5.95 |
| Digital capabilities and productivity enhancements investment <sup>(6)</sup> | 0.35 | 0.35 |
| As adjusted (Non-GAAP) <sup>(7)(8)(9)</sup> | $5.95 | $6.30 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6)In fiscal year 2026, the company expects to incur approximately $50-$60 ($38-$46 after tax) of operating expenses related to its digital capabilities and productivity enhancements investment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7)Adjusted EPS is defined as diluted earnings per share that excludes or has otherwise been adjusted for significant items that are nonrecurring or unusual. The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8)Adjusted ETR is defined as the effective tax rate that excludes or that has otherwise been adjusted for significant items that are nonrecurring or unusual.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9)Adjusted EPS and adjusted ETR are supplemental information that management uses to help evaluate the company's historical and prospective financial performance on a consistent basis over time. Management believes that by adjusting for certain items affecting comparability of performance over time, such as the pension settlement charge, incremental costs and insurance recoveries related to the August 2023 cyberattack, asset impairments, charges related to the streamlined operating model, charges related to the digital capabilities and productivity enhancements investment, significant losses/(gains) related to acquisitions / divestitures and other nonrecurring or unusual items, investors and management are able to gain additional insight into the company's underlying operating performance on a consistent basis over time. However, adjusted EPS and adjusted ETR may not be the same as similar measures provided by other companies due to potential differences in methods of calculation or differences in which items are incorporated into these adjustments.